Avanos Medical, Inc. (NYSE:AVNS) Position Lessened by New York State Teachers Retirement System

New York State Teachers Retirement System trimmed its position in shares of Avanos Medical, Inc. (NYSE:AVNS) by 12.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 78,006 shares of the company’s stock after selling 10,600 shares during the period. New York State Teachers Retirement System’s holdings in Avanos Medical were worth $1,750,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Gladius Capital Management LP purchased a new stake in shares of Avanos Medical during the third quarter worth $30,000. Meeder Asset Management Inc. raised its holdings in shares of Avanos Medical by 1,702.8% during the fourth quarter. Meeder Asset Management Inc. now owns 1,911 shares of the company’s stock worth $52,000 after acquiring an additional 1,805 shares in the last quarter. Captrust Financial Advisors raised its holdings in shares of Avanos Medical by 23.9% during the first quarter. Captrust Financial Advisors now owns 2,704 shares of the company’s stock worth $91,000 after acquiring an additional 521 shares in the last quarter. Tower Research Capital LLC TRC raised its holdings in shares of Avanos Medical by 134.0% during the second quarter. Tower Research Capital LLC TRC now owns 2,810 shares of the company’s stock worth $72,000 after acquiring an additional 1,609 shares in the last quarter. Finally, State of Wyoming raised its holdings in shares of Avanos Medical by 302.6% during the second quarter. State of Wyoming now owns 4,123 shares of the company’s stock worth $105,000 after acquiring an additional 3,099 shares in the last quarter. 95.17% of the stock is currently owned by hedge funds and other institutional investors.

Avanos Medical Price Performance

Shares of NYSE:AVNS opened at $18.66 on Wednesday. Avanos Medical, Inc. has a fifty-two week low of $17.24 and a fifty-two week high of $31.31. The business has a 50-day moving average of $19.34 and a two-hundred day moving average of $19.99. The stock has a market capitalization of $862.09 million, a P/E ratio of -14.13, a P/E/G ratio of 1.08 and a beta of 0.96. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.08 and a quick ratio of 1.38.

Avanos Medical (NYSE:AVNS) last announced its quarterly earnings results on Tuesday, February 20th. The company reported $0.36 earnings per share for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.01). Avanos Medical had a positive return on equity of 4.25% and a negative net margin of 8.76%. The company had revenue of $173.30 million during the quarter, compared to analyst estimates of $170.43 million. During the same period in the prior year, the firm earned $0.60 EPS. Avanos Medical’s quarterly revenue was down 4.6% on a year-over-year basis. On average, equities research analysts predict that Avanos Medical, Inc. will post 1.38 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded Avanos Medical from a “hold” rating to a “buy” rating in a report on Tuesday, March 19th.

Insiders Place Their Bets

In other Avanos Medical news, CFO Michael Greiner sold 8,000 shares of the business’s stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $19.12, for a total value of $152,960.00. Following the completion of the sale, the chief financial officer now owns 151,495 shares of the company’s stock, valued at $2,896,584.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 3.94% of the company’s stock.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.